2013 annual financial data
CytomX Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -901.8%.
Operating income was -14,956,000 USD and net income was -15,143,000 USD.
Operating cash flow was -8,008,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 888,000 USD
- Operating income
- -14,956,000 USD
- Net income
- -15,143,000 USD
- Operating cash flow
- -8,008,000 USD